Rijorab-LS is the combination of two powerful anti-ulcerants which address various complications associated with the acid-reflux issues and Helicobacter pylori infections.
Rabeprazole, which is a substituted benzimidazole, works as a proton pump inhibitor (PPI). Rabeprazole is activated in the acidic environment only. Rabeprazole gets absorbed by the parietal cells. After the activation, this drug binds to the H+/ K+ ATPase system present on the parietal cells and blocks the inward movement of H+ ions into the stomach and prevents the last step of acid production.
Levosulpiride possesses strong gastrointestinal motility properties due to which it is used as a digestive aid. Levosulpiride specifically blocks D2 receptors of dopamine both at central and peripheral levels. This drug does not have any effect on acetylcholine, serotonin, histamine, and GABA receptors.
Take the Rijorab-LS exactly as directed by your doctor. It is best to take one capsule daily on an empty stomach.
Use of Rijorab-LS should be avoided in patients with known allergy to any of the component or excipients of this medicine.
Yes, the use of Rijorab-LS can cause dizziness (feeling faint, weak, unsteady or lightheaded) in some patients. If you feel dizzy or lightheaded, stop what you are doing and sit or lie down for some time or until you feel better.
Several studies in adults suggest that treatment with Rijorab-LS may be associated with an increased risk for osteoporosis-related fractures of the hip, wrist or spine. The risk of fracture was increased in patients who received high-dose, defined as multiple daily doses, and long-term therapy (a year or longer).
No, taking Rijorab-LS may make you feel sleepy, dizzy or could affect your eyesight. So do not drive or use machines until you know how this medicine affects you.